KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Short term Debt (2016 - 2025)

Historic Short term Debt for Pacira BioSciences (PCRX) over the last 15 years, with Q2 2025 value amounting to $202.4 million.

  • Pacira BioSciences' Short term Debt changed N/A to $202.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $202.4 million, marking a year-over-year change of. This contributed to the annual value of $201.8 million for FY2024, which is 223510.01% up from last year.
  • Per Pacira BioSciences' latest filing, its Short term Debt stood at $202.4 million for Q2 2025.
  • Over the past 5 years, Pacira BioSciences' Short term Debt peaked at $350.5 million during Q4 2021, and registered a low of $8.6 million during Q3 2023.
  • In the last 5 years, Pacira BioSciences' Short term Debt had a median value of $151.6 million in 2021 and averaged $113.4 million.
  • Its Short term Debt has fluctuated over the past 5 years, first plummeted by 9321.69% in 2023, then soared by 223868.77% in 2025.
  • Quarter analysis of 5 years shows Pacira BioSciences' Short term Debt stood at $350.5 million in 2021, then plummeted by 90.4% to $33.6 million in 2022, then tumbled by 74.32% to $8.6 million in 2023, then skyrocketed by 2235.1% to $201.8 million in 2024, then rose by 0.31% to $202.4 million in 2025.
  • Its Short term Debt was $202.4 million in Q2 2025, compared to $202.1 million in Q1 2025 and $201.8 million in Q4 2024.